ClinicalTrials.Veeva

Menu

Lymphoma and T Helper 2 Cytokines Relationship With Prognostic Markers

N

Nil Guler

Status

Completed

Conditions

Lymphoma

Study type

Observational

Identifiers

NCT01639716
NG6420 (Other Grant/Funding Number)
NG63900

Details and patient eligibility

About

The investigators hypothesized that Non Hodgkin lymphoma is using T helper 2 pathways. So that the investigators decided to study of cytokines related to T helper 2 pathways. It is well known that parasites and allergic situations also use T helper 2 pathways. Because that the investigators excluded the patients have parasites and allergic situations. All the patients were over 18. The investigators included the patients with non Hodgkin lymphoma which new diagnosed. It is observational study. The investigators took blood before chemotherapy and four months later. The investigators did not interfere with which chemotherapy will be given to patients. This decision was belong to hematologist or oncologist who will treat the patient.

Enrollment

58 patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • newly diagnosed non hodgkin lymphoma
  • Diffuse large B cell lymphoma and T cell lymphoma patients

Exclusion criteria

  • under 18 age
  • parasitosis
  • allergic status

Trial design

58 participants in 7 patient groups

Lymphoma group
healthy group
IL-10 high
IL-10 low
IL-4 high
IL-4 low
lymphopenia

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems